Atlas Trials

Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer

Clinical trial NCT05601505 · RECRUITING

Trial details

NCT number
NCT05601505
Sponsor
Peking Union Medical College Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Locally Advanced Rectal CarcinomaCirculating Tumor DNA
Start date
2023-02-03
Primary completion
2025-10-31
Enrollment
470

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.